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Abstract
Liver resections are usually considered the treatment of choice for colorectal and neuroendocrine metastases. Recently, the
morbidity and mortality rates for liver surgery have dramatically decreased. Therefore, hepatic resection has been applied in
selected cases of non-colorectal, non-neuroendocrine hepatic metastases. We report our experience with three cases of liver
metastases from lung carcinoma and review the literature, to evaluate the role of liver surgery for this indication.
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Introduction
Liver resection is the treatment of choice for isolated
colorectal (CR) hepatic metastases, and since
chemotherapy provides responses in a minority of
cases with no chance of cure, aggressive surgery has
been advocated even for advanced CR hepatic metas-
tases with satisfying results [1/3]. In the case of
neuroendocrine metastatic tumors, an aggressive
surgical approach is considered the treatment of
choice (including liver transplantation), and even
debulking surgery may improve survival [4,5].
The role of liver resection for non-colorectal, non-
neuroendocrine hepatic metastases is still a matter of
discussion. Few authors have recently reported satis-
fying results after liver resections for non-colorectal,
non-neuroendocrine metastases [6/9].
We report the clinical data and outcome of three
cases of partial hepatectomy for lung metastases and
review the data in the literature.
Patients and methods
From November 1990 to March 2003, 144 patients
with non-colorectal, non-neuroendocrine hepatic
metastases were admitted to the Department of
Surgery and Transplantation, University of Bologna.
A curative liver resection was performed in 85 cases
(59%).
Among these 85 cases, 3 (3.5%) patients were
operated on for liver metastases from lung carcinoma.
Selective diagnostic work-up for these patients
included the evaluation of liver function, ultrasonog-
raphy, chest X-ray, abdomen spiral CT scan (total
body scintigraphy to exclude other localizations) and
PET (positron emission tomography) scan in the last
case. The presence of extrahepatic disease at the
preoperative evaluation was considered an absolute
contraindication to surgery.
Results
The patients’ features and outcomes are reported in
Table I. The three patients were 63, 52 and 60 years
old, respectively. Two were male and one female. In
the first case, liver metastasis was synchronous with
lung carcinoma. In the other two cases, pulmonary
lobectomy was performed 24 and 18 months before
diagnosis of hepatic metastases, respectively. All
operations were carried out in B/5 hours and
intraoperative blood transfusion volumes were
600 ml and 500 ml in the first and third case,
respectively. No blood transfusion was required in
the second case.
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Postoperative hospital stay was 12, 7, and 10 days,
respectively, and none of the patients experienced
major postoperative complications. In all three cases,
adjuvant chemotherapy was administered.
Discussion
The role of liver resection for non-colorectal, non-
neuroendocrine hepatic metastases is still quite con-
troversial. However, while available data indicate a
poor survival in patients with unresectable metastases,
a 5-year survival rate between 20% and 37% can be
expected after curative liver resection in selected cases
[6/9].
Refinements in perioperative care and surgical
techniques have significantly improved the safety of
liver surgery, and operative mortality has decreased to
around 1% in tertiary referring centers [2,3]. For
these reasons, in the last 10 years liver resection has
been proposed not only for colorectal and neuroendo-
crine metastases, but also for metastatic tumor from
other sites.
It has been reported that patients with single lesions
are the best candidates for surgery and have the
greatest chance of long-term survival. In addition,
patients with a long disease-free interval after resec-
tion of primary tumor can be expected to have better
prognosis compared with patients with a short dis-
ease-free interval [7,9]. In this series, we selected
patients with one or two nodules. The patient with
synchronous metastases was operated on at the
beginning of our experience.
Liver resections for lung metastases are very rare
and few cases are reported in the literature, usually
together with the entire series of non-colorectal, non-
neuroendocrine hepatic metastases. In the largest
reported experience with three cases, the outcome
was not shown [8] as well as in other series. On the
contrary, some cases of long-term survival have been
reported [6,8,10]. In our experience postoperative
morbidity and mortality were absent. There was one
patient who survived 3 years and one is still alive. It is
not possible to give definitive conclusions on the role
of surgery for hepatic metastases from lung cancer.
However, whenever extrahepatic disease is excluded,
in selected cases with one or two nodules, and when
disease-free interval resection of primary tumor is
longer than 1 year, acceptable results can be achieved,
and surgery should be given as a therapeutic option at
least until new effective chemotherapeutic agents are
developed.
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Table I. The patients’ features and outcomes.
Patient
Pathology of the
primary tumor
Date of
operation
Number of liver
metastases
Diameter of the
largest liver
metastases (cm)
Type of hepatic
resection Follow-up
R.R. Bronchial adenocarcinoma July 1988 1 2 Segmentectomy,
(segment V)
Died after 1 year
from recurrence
C.M. Bronchial adenocarcinoma July 1991 1 5 Segmentectomy,
(segment VI)
Died after 3 years
from recurrence
D.A. Bronchial adenocarcinoma October 2004 2 6 Right hepatectomy Alive without
recurrence
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